COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ DE PRESSE
Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
Marinomed Biotech AG announces 2023 financial year results, highlighting progress with Marinosolv and Carragelose assets. Focus on achieving operating profitability and commercialization -
COMMUNIQUÉ DE PRESSE
PharmaSGP exceeds the € 100 million revenues mark in 2023 and plans further profitable growth in 2024
PharmaSGP surpasses €100 million revenues in 2023, plans growth in 2024. Achieved 17.8% revenue increase and 20.8% rise in adjusted EBITDA. Forecasts €107-112 million revenues and €35-38 million EBITDA for 2024 -
-
-
COMMUNIQUÉ DE PRESSE
Swiss Prime Site completes acquisition of the real estate asset manager Fundamenta Group
Swiss Prime Site AG completes acquisition of real estate asset manager Fundamenta Group, becoming the largest independent asset manager in Switzerland with CHF 13 billion in assets under management -
COMMUNIQUÉ DE PRESSE
Swiss Prime Site finalise l'acquisition du gestionnaire d'actifs immobiliers Fundamenta Group
Swiss Prime Site finalise l'acquisition du gestionnaire d'actifs immobiliers Fundamenta Group, devenant ainsi le plus grand gérant indépendant en Suisse avec CHF 13 milliards d'actifs sous gestion -
COMMUNIQUÉ DE PRESSE
Supplementary announcement on the payment of the cash distribution from the capital reduction of STRABAG SE (ISIN AT000000STR1) resolved on 16 June 2023 via a value right (ISIN AT0000A36HK3)
STRABAG SE announces cash distribution payment from capital reduction via value rights (ISIN AT0000A36HK3), submission period extended. Payment date 17 May 2024. More info at www.strabag.com -
COMMUNIQUÉ DE PRESSE
DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market
DocMorris continues to grow in the first quarter of 2024 with a 10.3% revenue increase. They introduce digital access to the entire e-prescription market, aiming for sustainable growth -
